- MACK Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Merrimack Pharmaceuticals (MACK) S-3Shelf registration
Filed: 15 Dec 17, 12:00am
Exhibit 12.1
Calculation of Consolidated Ratios of Earnings to Fixed Charges
9/30/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||||||||||||||||||
Fixed Charges: | ||||||||||||||||||||||||
Interest expense on indebtedness | $ | 2,035 | $ | 2,716 | 10,365 | $ | 9,717 | 6,408 | 466 | |||||||||||||||
Noncash interest expense and other | 3,297 | 19,733 | 8,404 | 8,510 | 4,530 | 88 | ||||||||||||||||||
Interest expense on portion of rent expense representative of interest | 1,099 | 1,554 | 1,428 | 1,140 | 1,822 | 1,439 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Total Fixed Charges | 6,431 | 24,003 | 20,197 | 19,367 | 12,760 | 1,993 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Earnings (loss): | ||||||||||||||||||||||||
Net income (loss) before benefit for income taxes | (96,457 | ) | (169,508 | ) | (162,834 | ) | (47,083 | ) | (97,917 | ) | (66,920 | ) | ||||||||||||
Fixed charges per above | 6,431 | 24,003 | 20,197 | 19,367 | 12,760 | 1,993 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Total earnings (loss) | (90,026 | ) | (145,505 | ) | (142,637 | ) | (27,716 | ) | (85,157 | ) | (64,927 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Ratio of earnings to fixed charges | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||
Deficiency of earnings available to cover fixed charges | (96,457 | ) | (169,508 | ) | (162,834 | ) | (47,083 | ) | (97,917 | ) | (66,920 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|